Skip to main content
Pharmacogenomic Testing

The Right Drug. The Right Dose.
For Every Patient.

Precision Genomics eliminates trial-and-error prescribing through clinically validated pharmacogenomic testing — giving providers the genetic insights they need to prescribe smarter from day one.

31%
Reduction in Morphine Milligram Equivalents (MME)
42%
Fewer Emergency Department Visits
100%
Drug-Gene Interactions Identified
83%
Prescription Optimization Rate
Every patient carries genetic variants that affect drug response. We decode them.

Precision Medicine Starts With
Precision Genomics

Pharmacogenomics (PGx) is the study of how your genes affect your response to medications. At Precision Genomics, we translate this science into actionable clinical tools.

We partner with health systems, pain management clinics, and provider groups to implement pharmacogenomic testing programs that reduce adverse drug events, lower opioid utilization, and improve patient outcomes — all backed by real-world clinical evidence.

Our Mission

To make genetically guided prescribing the standard of care — not the exception — by providing accessible, clinically validated pharmacogenomic testing and expert interpretation to every healthcare provider who needs it.

What We Test

Our comprehensive PGx panel analyzes key pharmacogenes that influence drug metabolism, efficacy, and adverse reaction risk across therapeutic areas including pain management, cardiology, psychiatry, and oncology.

Gene Panel
CYP2D6 CYP2C19 CYP2C9 SLCO1B1 TPMT HLA-B VKORC1 DPYD CYP1A2 CYP3A4/5
Clinical Focus

Pain Management · Cardiology · Psychiatry · Oncology · Primary Care

Clinical Services

From sample collection to ongoing support, Precision Genomics provides end-to-end pharmacogenomic services tailored to your clinical environment.

🧬

PGx Panel Testing

Comprehensive multi-gene pharmacogenomic panel covering 10+ key pharmacogenes. Simple buccal swab collection with results in 3-5 business days.

Core Service
📋

Clinical Reporting

Actionable, provider-friendly reports with medication-specific recommendations, phenotype classifications, and drug interaction flags — no genetics degree required.

Provider Tools
💊

Opioid Stewardship

Evidence-based opioid management guided by CYP2D6 and CYP2C19 genotyping. Documented 31% MME reduction across enrolled patients in clinical studies.

Pain Management
🏥

Health System Integration

Seamless integration with existing EHR workflows, clinical decision support tools, and pharmacy systems. Designed to fit your operations — not disrupt them.

Enterprise
🎓

Provider Education

CME-eligible training programs for physicians, pharmacists, and nursing staff. We ensure your team understands PGx results and applies them confidently.

Education
🤝

Patient Counseling

Dedicated genetic counseling support to help patients understand their results, medication changes, and the long-term benefits of genetically guided therapy.

Patient Care

How It Works

From sample to treatment plan — our streamlined process delivers actionable genetic insights to providers within days.

  1. 1

    Sample Collection

    Simple buccal (cheek) swab collected at point of care. Non-invasive, painless, and takes less than 30 seconds.

  2. 2

    Genetic Analysis

    Samples are analyzed at our CLIA-certified laboratory using validated genotyping platforms.

  3. 3

    Expert Interpretation

    Board-certified pharmacogenomicists interpret results using CPIC guidelines and current clinical evidence.

  4. 4

    Actionable Report

    Providers receive a clear, medication-specific report with dosing recommendations and interaction alerts.

  5. 5

    Ongoing Support

    Our clinical team provides follow-up consultation, EHR integration support, and patient counseling resources.

Why Pharmacogenomics Matters

The evidence is clear: PGx-guided therapy reduces adverse drug events, lowers costs, and improves patient outcomes across therapeutic areas.

31%
Reduction in opioid MME with PGx-guided prescribing
PGx-ACT Study, 2025
42%
Fewer ED visits among PGx-tested patients
JMIR Medical Informatics, 2022
$1,200
Average annual savings per PGx-tested patient
Smith et al., Pharmacogenomics, 2019
7%
Of the population are CYP2D6 poor metabolizers — at highest risk
CPIC Guidelines
🎯

Eliminate Trial-and-Error

Stop cycling patients through medications that their genetics predict won't work. Get it right the first time with PGx-guided prescribing.

🛡️

Reduce Adverse Events

Adverse drug reactions cause over 100,000 deaths annually in the U.S. Genetic testing identifies patients at risk before the first dose.

📉

Lower Healthcare Costs

Fewer ER visits, fewer failed medication trials, shorter hospital stays. PGx testing pays for itself through reduced downstream utilization.

⚖️

Support Regulatory Compliance

Over 300 FDA-approved drugs now include pharmacogenomic information in their labeling. PGx testing aligns with evolving standards of care.

What Providers Are Saying

Hear from healthcare professionals who have implemented PGx testing in their practice.

Implementing PGx testing through Precision Genomics transformed our pain management approach. We've seen measurable reductions in opioid prescribing and significantly better patient outcomes. The clinical reports are clear, actionable, and easy to integrate into our workflow.
Dr. Webster, MD Pain Management
The level of clinical support we receive is outstanding. Precision Genomics doesn't just send us a test result — they provide expert interpretation and follow-up that makes a real difference in how we manage complex patients.
Caitlin H., PharmD Clinical Pharmacist
It is my privilege to recommend the implementation of the Precision Genomics Pharmacogenomic (PGx) Testing Program in the skilled nursing setting. As a Chief Nursing Officer with extensive experience in long-term and post-acute care, I have seen firsthand the challenges of medication management among older adults with complex conditions and polypharmacy. I strongly endorse Precision Genomics' Testing Program as a valuable and forward-thinking initiative for skilled nursing facilities. Its impact extends beyond clinical improvement — it demonstrates a commitment to innovation, safety, and excellence in long-term care.
Bryanna Wegner, RN, BSN, MA Chief Nursing Officer — HMR Veteran Services

Ready to Implement PGx Testing?

Contact our team to learn how pharmacogenomic testing can improve outcomes and reduce costs in your clinical environment. We'll walk you through the process, answer your questions, and design a program that fits your workflow.

📍
4850 Goodman Road, Suite 101
Olive Branch, MS 38654
Clinical Disclaimer: Pharmacogenomic testing is a clinical laboratory service intended for use by licensed healthcare providers. Test results are interpretive and should be used in conjunction with clinical judgment, patient history, and established treatment guidelines.